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407-3 Estrogen Augments Incorporation of Bone Marrow- 
Derived Endothelial Progenitor Cells Into Sites of 
Myocardial Neovascularization 
Atsushi Iwakura. Corinne Luedemann, Atsuhiko Kawamoto, Shubha Shastry, Takayuki 
Asahara, Douglas W. Losordo, St. Elizabeth’s Medical Center, Boston, MA 
Background: We hypothesized that estrogen augments incorporation of bone marrw 
(EM)-derived endothelial progenitor cells (EPCs) into sites of neovascularization after 
myocardial infarction (Ml). Methods and Results: Ml was induced by ligation of left core- 
nary artery in 67 ovariectomized FVB mice receiving either 178.estradiol or placebo. Left 
ventricular (LV) function within 2 weeks after MI, assessed by echocardiography and 
catheter tipped manometer, was similar between the groups. However, LV systolic and 
diastolic dimensions and fractional shortening in the estrogen group were preserved 3 
and 4 weeks after Ml as compared to placebo. LV +dPldt and -dP/dt 4 weeks after Ml I” 
the estrogen group were also higher than placebo Capillary density 4 weeks after MI 
was significantly greater in estrogen group (P<O.Ol) Furthermore, ratio of fibrosis area to 
LV area in the estrogen group was significantly lower than placebo (P<O.O5). In cultured 
EPC assay, significant increases in circulating EPCs 2 and 3 weeks after Ml were 
observed I” the estrogen group as compared to placebo (2 wks, 3 wks: PcO.01) To eval- 
uate the effects of estrogen on BM-derived EPCs at the sites of myocardial neovascular- 
ization, we made Ml models using 21 ovariectomized FVB mice transplanted with BM 
from transgenic donors expressing O-galactosidase transcriptionally regulated by endot- 
helial cell-specific Tie-2 promoter. More X-gal positive cells were observed at ischemic 
sites in the estrogen group 1 and 4 weeks after Ml as compared to placebo (Iwk: PcO.05, 
4 wks: PcO.01). Fluorescent immnohistochemistry 1 week after MI documented a 
marked increase I” cells that were double positive for B-gal and endothelial cell-specific 
marker tsolectin 84 in the estrogen group. By using immunohistochemistry and western 
blotting, VEGF expression in the estrogen group was increased both in the infarcted and 
non-infarcted areas 1 week after MI, although eNOS expression was similar between the 
groups. 
Conclusions: Estrogen attenuates LV remodeling and preserves LV function after Ml by 
augmenting incorporation of BM-derived EPCs into sites of myocardial neovasculariza- 
tion that might partially be mediated by VEGF. 
11:45 a.m. 
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407-l Reduction of No-Reflow and Infarct Size by lntraaortic 
Balloon Counterpulsation in a Randomized Magnetic 
Resonance Imaging Experimental Study 
Luciano Amado, Dara L. Kraitchman, Bernhard Gerber, Em&o Castlllo, Raymond C. 
Boston, Joseph Grayzel, Joao A. C. Lima, Johns Hopkins University, Baltimore, MD . 
Background: Presence of microvascular obstruction or “no reflow” (NR) within reperiused 
infarcts has been shown to negatively influence left ventricular (LV) remodeling after 
acute myocardlal Infarction (Ml) Intra-aortic balloon counterpulsation (IABC) can 
improve climcal outcomes post-MI but the mechanisms of such effect remain unclear. 
We hypothesized that IABC augmentation ameliorates microvascular obstruction, hence 
reduces the degree of NR. thereby decreasing the final Ml size. 
Methods: Seventeen dogs underwent 90 minutes of closed chest coronary artery occlu- 
sion followed by reperfusion. Animals were randomzed to either IABC (n= 9) or no IABC 
(control, n= 8) after reperfusion. IABC augmentation was performed for the first 24 hours 
post-MI. NR at contrast first- pass and infarct size by delayed-enhancement were mea- 
sured by contrast enhanced (CE) MRI during 24 hours after reperfusion. and compared 
with NR and risk region by microspheres blood flow defined as ~50% of remote flow and 
post-mortem TTC staining. 
Results: Data are presented as percentage of LV mass (Mean&SE). NR decreased sig- 
nificantly in IABC (4.9i2.2; 3.6*1.5 % at 1, and 24 hours, respectively) compared to con- 
trols (3.4+0.5 to 4.8+1.1 % at 1. and 24 hours, respectively; p< 0.01). There was h!gh 
correlation behhreen NR by MRI and microspheres (r= 0.90 and I= 0.83, at lh and 24 
hours, respectwely; p= 0.001) and a good correlation between Ml size by MRI at last time 
point and post-mortem data (r=O.73; p< 0.001). Infarct size by MRI increased with time in 
both groups (from 13.2i1.6 to 15.5i2.1 % at 1 h and 24 hours, respectively; p< 0.05). 
However, Infarct size enlargement at 24 hours in the IABC group (14 % increase) was 
stgnlficantly less than in controls (20 % increase, p< 0.05 between groups). 
Conclusion: IABC performed after reperfusion reduces the extent of NR caused by 
microvascular obstruction in acute Ml. By lmprovlng reperfusion of infarcted myocardium. 
IABC mitigates MI size growth. 
11:15a.m. 
407-2 Real-Time Magnetic Resonance Imaging for Integrated 
Identification, Targeting, and Injection of Labeled Stem 
Cells to Porcine Myocardial Infarction 
Alexander J. Dick, Michael A. Gunman, Venkatesh K. Raman, Dana C. Peters, Jonathan 
M. Hill, Scott Smith, Greig Scott, Elliot R. McVeigh, Robert J. Lederman, National Heart 
Lung and Blood Institute, Bethesda, MD 
Background: Catheter navigation and myocardial infections have previously been dem- 
onstrated under real-time magnetic rescmance imaging (RT-MRI) guidance. Potential 
applications Include transcatheter injections of therapeutic cell preparations. To be clini- 
cally useful, such technology should combine robust Identification of target pathology, 
device navigation, and cell delivery. We test the feasibility of RT-MRI for both the identifi- 
cation of myocardial infarctions (Ml) and targeted delivery of labeled mesenchymal Stem 
cells (MS&) into infarct borders. 
Methods: Porcine MSCs were dually MRI- and fluorescence-labeled using intracellular 
iron-fluorophore particles (IFPs). In five miwswine, one to seven days pnor to the RT- 
MRI study, Ml was induced by percutaneous coronary artery coil-occlusion. Transfemo- 
ral delivery catheters and Injection needles (Stiletto TM, Boston Scientifc) were modified 
to serve as MRI receiver coils. A 1.5T clinical MRI scanner was customized with rapid 
image reconstruction and Interactive features to enhance interventlonal guidance Con- 
trast between normal and infarcted myocardium was enhanced by intravenous injection 
of O.Pmmol/kg Gd-DTPA resulting in delayed hyperenhancement of the infarct. 
Results: Real-time steady state free-precession imaging with echo-sharing yielded 7 
frames/s of 1.7x3.3x8mm voxels. Catheter naviaation and multiple cell iniections were 
performed wholly under RT-MRI guidance. Targets were selected based on hyperen- 
hancement and wall motion abnormalities of Infarcted tissue. IFP-labeled MSCs were 
readily visualized in viva by MRI as a slgnal void and post-mortem using confocal fluores- 
cence microscopy. 
Conclusion: Targeted delivery of potentially regenerative cellular treatments to infarcted 
myocardium is feasible using multiple catheter coils and RT-MRI visuallzatlon of catheter 
navigation, myocardial function, tissue characteristics, and labeled cells. 
407-4 C-Reactive Protein Directly Attenuates Nitric Oxide 
Release and Bioactivity 
SubodhVerma Shu-Hong Li, Richard D. We&l, Toronto General Hospital, Toronto, ON, 
Canada 
Background: Given the central importance of nltrlc oxide (NO) in the development and 
clinical course of cardiovascular disease?., we sought to determine whether the powerful 
predictive value of C-reactive protein (CRP) might be explained through an effect on NO 
production. 
Methods and Results: Endothelial cells (ECs) were incubated with recombinant CRP (0 
to 100 pg/mL, 24 hours), and NO and cyclic guanoslne monophosphate (cGMP) produc- 
tion was assessed. The effects of CRP on endothelial NO synthase (eNOS) protein, 
mRNA expression, and mRNA stability were also examined. In a separate study, the 
effects of CRP (25 pg/mL) on EC cell survival, apoptosls, and in vitro angiogenesis were 
evaluated. Incubation of ECs with CRP resulted in a significant inhibition of basal and 
stimulated NO release, with concomitant reductions rn CGMPproduction. CRP caused a 
marked downregulation of eNOS mRNA and protein expression. Actinomycin D studies 
suggested that eNOS downregulation was related to decreased mRNA stability. In con- 
IunctIon with a decrease in NO production, CRP inhibited both basal and vascular endot- 
helial growth factor-stimulated angiogenesls as assessed by EC migration and capillary- 
like tube formation. CRP did not induce EC survival but did, however, promote apoptosis 
in a NO-dependent fashion. 
Conclusions: CRP, at concentrations known to predict adverse vascular events, directly 
quenches the production of the NO, in part, through posttranscriptional effect on eNOS 
mRNA stability. DiminIshed NO bioactivity. in turn, inhibits angiogenesis. an important 
compensatory mechanism in chronic ischemia. Through decreasing NO synthesis, CRP 
may facilitate the development of diverse cardiovascular diseases. Risk reduction strate- 
gies designed to lower plasma CRP may be effective by improving NO bioavailability. 
Noon 
407-5 Circulating and Tissue Angiotensin II Type 1 Receptors 
From Perioperation Through One-Year of 
. Transplantation: A Potential Molecular Mechanism for 
Cardiac Allograft Vasculopathy 
Mohammed Yousufuddin, Randall C. Starling, E. Murat Tuzcu, Ashraf Abdo, Philip Paul, 
Showkat Haji. Norman B. Ratliff, Daniel J. Cook, Yasser Saad, Sadashiva Kamik, Patrick 
M. McCarthy, James B. Young, Mohamad H Yamani, Cleveleand Clinic Foundation, 
Cleveland, OH 
The precise molecular mechanism underlying the accelerated progression of cardiac 
allograft vasculopathy (CAV) after transplantation is not known. Objectives and Meth- 
ods: We, therefore, attempted to determine whether angiotensin II (Ang II) receptor type 
1 (AT,) expression, which was assessed by real-time quantitative RT-PCR using Taq- 
Man system (Applied Blosystems, CA) during perioperative period through one year after 
transplantation predicts the development of CAV measured as change in maximal intimal 
thickness (CMIT) and plaque volume (CPV) at worst affected sites by intravascular ultra- 
sound (IVUS). We estimated AT, mRNA expreswn of 1) donor lymphocytes-derived 
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nave abundance and the protein levels for MMPs, respectively. 
Results: One micro mollL BNP significantly (pcO.01) enhanced zymographic gelatinase- 
A (MMP-2) abundance. In addition, protein expressions of MMP-1. -2, -3 and membra- 
nous type-l MMP were significantly increased by BNP, while MMP-9 and MMP-13 were 
unchanged. The cGMP analogue &bromo-cGMP (lo4 moliL) mimicked the BNP effect, 
whereas inhibition of protein kinase G (PKG) by KT5823 (lo* moUL) significantly 
(p-zO.05) attenuated BNP-induced zymographic MMP-2 abundance. ET-l (lo” mti) 
down-regulated the zymographic MMP-2 abundance and BNP reversed the action of ET- 
1, while TNF-alpha (lO-7 mol/L) increased BNP-induced zymographic MMP-2 abundance 
in a synergistic manner. 
Conclusions: This study reports that BNP increases MMPs via cGMP-PKG signaling. In 
addition, cross-talk between BNP and ET-l, TNF-alpha results in different biological 
effects. These findings suggest that BNP participates in the remodeling of myocardial 
structure in the progression of heart failure via the control of cardiac fibroblast function. 
2:30 pm. 
409-3 Identification of Differential Gene Expression Patterns 
in Patients With End-Stage lschemic and Noniachemic 
Cardiomyopathies 
Xinaiana Han, David Fermin. Jennifer Hall, Soon Park, Richard A. King, Leslie W. Miller, 
University of Minnesota Medical School, Minneapolis, MN 
Background: End-stage cardiomyopathy (ESCM) is associated with altered expressions 
of muitiple genes. Unloading by the left ventricular assist device (LVAD) which results in 
recovery of hemodynamic and cellular abnormalities may lead to further dynamic gene 
expression changes. 
Methods: A microarray technique representlng approximately 2l3 of known human 
genome (22283 genes, Affymetrix) was used to probe paired left ventricular samples 
from 15 patients (7 ischemic, 8 non-ischemic, on LVAD for 1 to 22 months) obtained at 
LVAD implant and transplantation; real-time polymerase chain reaction (RT-PCR) was 
used to further confirm selected gene transcript changes. 
Results: At a p value of ~0.01, at least 196 genes encompassing both cell structure pro- 
tein/matrix and subcellular signaling proteins regulating inotropy, metabolism, myocardial 
hypertrophy and apoptosis were differentially expressed between ischemlc and non- 
ischemic ESCM. In ischemlc ESCM, LVAD support resulted in increase of 68 genes and 
decrease of 81 genes. In non-lschemic ESCM, LVAD support resulted I” increase of 50 
genes and decrease of 3 genes. Five genes (Ribosomal protein L4, Heterogeneous 
nuclear ribonucleoproteln, Glycine amidinotransferase, Aquaporin 7, and KIAA0713 pro- 
tein) were found concordantly altered in both ischemic and non-ischemic ESCM. How- 
ever, these five genes responded very differently to unloading by LVAD. When patients 
were grouped by the duration of LVAD support (Month: < 2,2-10, >lO), a greater number 
of genes were found altered with longer LVAD support and the majority of genes in each 
of the three duration groups were distinct. RT-PCR experiments using specific primers 
designed for natriuretic peptide precursor B, collagen type la, four and a half LIM 
domains I, and myosin light chain 2a confirmed the microarray finding that the first two 
genes were down-regulated and the last two genes were up-regulated following LVAD. 
Conclusion: lschemic and non-ischemic ESCM are associated with dynamic and differ- 
ential expressions of different genes. Remodeling following LVAD is likely en active pro- 
cess involving activation and inactivation of different functioning groups of genes in the 
two disease entities. 
2:45 p.m. 
from spleen (DSL), 2) surveillance right ventricular endomyocardial biopsies (EMB) 
obtained at l-week and l-year after transplantation in 28-patients (age: recipient 55 f 
11.8; donor 32 *7 years) who had a paired IVUS within 4-weeks and at one year after 
transplantation for the volumetric assessment of CAV. Results: AT, mRNA expression 
in DSL (median and 25th -75th percentile: 9.9, 3.1 - 23.8 folds relative to calibrator) cor- 
related with that of EMB at l-week (1.04, 0.6 - 2.0 folds; r = 0.60, P = 0.001) and at 1-yr 
(1.5, 0.6 - 3.8 folds; r = 0.66, P = 0.0003) after transplantation. mRNA expression of AT, 
in DSL (CMIT: r=0.73. PC 0.0001; CPV: r = 0.69, P < 0.0001) and EMB at 1 -week (CMIT: 
r=O.52, F10.005;CPV: r=0.56. EO.002) and at 1-yr (CMIT: rc0.63, P < 0.0001; CPV: 
r=0.43, F10.004) aHer transplantation were univariate predictors of CAV. Multivariate 
analysis showed that mRNA expression of AT, in DLS (P= 0.01) and in l-year EMB (P= 
0.03) as significant predictors of CAV with a combined r of 0.87 and I+ of 0.75. AT, 
expression in DLS (7.4t9.8 vs 22.1+16.0 folds;F=0.004) and in EMBs at l-year (1.3 +1.6 
vs 3.le2.5 folds; P=O.Ol) were higher in recipients (n=l3) demonstrating CAV es a more 
than 0.3mm CMIT from baseline to one year. Conclusions: mRNA expression of AT, in 
DSL correlate with that of early and one-year post transplant cardiac expression. Both 
DSL and cardiac AT, expression predict accelerated progression of CAV supporting a 
potentially important role of Ang II receptor blocker in retarding its progression after 
transplantation. 
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409-l Local Delivery of Culture-Modified Mononuclear Cells 
Improves Endothelial Function and Attenuates 
Neointimal Formation in a Rabbit Balloon Injury Model 
Raiiv Gulatl, Dragan Jevremovic. Timothy E. Peterson, Tyra A. Win, Laurel S. Kleppe. 
Cheryl S. Mueske, Amir Lerman, Richard G. Vile, Robert D. Simari, Mayo Clinic, 
Rochester, MN 
Background: Bone marrow derived progenitor cells have been shown to contribute to 
endothelial replacement following vascular injury. In vitro culture of peripheral blood pro- 
duces cells with phenotypic characteristics of endothelium. We hypothesized that autolo- 
gous delivery of such culture-modified mononuclear cells (CMMC) to balloon injured 
arteries could beneficially modify the vascular response to injury. 
Methods and Results: Rabbit peripheral blood mononuclear cells were cultured on 
fibronectin in endothelial growth media for 7 days yielding cells of endothelial lineage 
(CMMC). Continued culture resulted in highly proliferative outgrowth of cells with distinct 
endothelial phenotype (CD31, eNOS, acetylated LDL uptake). A rabbit model of balloon 
carotid injury was used to evaluate the effect of CMMC delivery on functional and struc- 
tural vascular responses. Animals underwent balloon injury and immediate treatment 
with autologous CMMCs or saline control by 20 minutes of local dwelling or by systemic 
ear vein injection. Fluorescent labeled CMMCs were seen to incorporate into the vessel 
wall following both routes of delivery. Local CMMC administration at the time of balloon 
inlury dramatically improved endothelial dependent vasoreactivity to acetylcholine (Ach) 
at 4 weeks compared with salme treatment (% max relaxation 77.6 +I- 6.4 vs 28.8 +I- 7 6. 
p&lt;0.005; concentration Ach [-log M] to achieve 25% mex relaxation 7.19 +/- 0.04 vs 
5.38 +/- 0.06, p&lt;O.O05). CMMC treatment also significantly reduced neointimal forma- 
tion at 4 weeks (intJmed 0.39 +I- 0.08 vs 0.86 +/- 0.17, p&lt;O.O5). 
Conclusions: These data demonstrate that delivery of CMMCs to balloon injured arteries 
is associated with markedly enhanced endothelial dependent vasoreactivity. Further- 
more, CMMCs delivered at the time of injury significantly reduce subsequent neointimal 
formation. 
2:15 pm. 
409-2 Antifibrotic Property of Brain Natriuretic Peptide in 
Cardiac Fibroblasts: Cross-Talk Action With 
Endothelin-1 and Tumor Necrosis Factor on the 
Induction of Matrix Metalloproteinases 
Toshihiro Tsuruda. Guido Boerngter, Brenda K. Huntley, Josh A. Noser, Alessendro 
Ceteliotti, John C. Burnett, Jr., Mayo Clinic. Rochester, MN 
Background: Cardiac fibroblasts (CFs) produce extracellular matrix (ECM) proteins and 
participate in the remodeling of the heart. Brain natriuretic peptide (BNP) is known to be 
activated in heart failure, and inhibit cellular proliferation; however, it is unknown if BNP 
participates in the degradation of ECM turnover. To understand the role of BNP es an 
anti-fibrotic factor in the progression of heart failure, we examined the effect of BNP and 
its signaling system on the activation of matrix metalloproteinases (MMPs), a key 
enzyme for the degradation of ECM proteins. In addition, we looked at the interactions 
between BNP and a fibrotic factor, endothekn-1 (ET-l), and a pro-inflammatory cytokine, 
TNF-alpha. 
Methods: CFs isolated from normal adult canine ventricle were used. Techniques for 
zymographic gelatlnase assay and Western bloning were employed to detect the gelati- 
409-4 Combinatorial Cytokine Gene Therapy Induces 
Synergistic lmmunosuppression and Tolerance in 
Cardiac Allograft 
Hiroshi Furukawa Kiyohiro Oshima. Hyde Russell, Thomas Tung, Jun Xu, Guanggen 
Cui, Hillel Laks, Luyi Sen, UCLA, Los Angeles, CA 
Background: Previous studies have shown that ex viva interleukrn-10 (IL-lo) gene ther- 
apy suppressed alloimmune responses and prolonged allograft surwval, but true toler- 
ance was not achieved. We assessed the hypothesis that liposome-mediated ex viva 
intracoronary Interleukin-4 (IL-4) and IL-10 comblned gene therapy may generate syner- 
gistic immunosuppression and induce allograft tolerance. 
Methods: A functional cervical heterotopic heart transplant model of rabbits was used to 
evaluate the efficiency and efficacy of the gene therapy. 
Results: The mean survival of cardiac allografl was significantly (pqO.05) prolonged from 
7*1 days in Control Group (CG) to 28a7 days in IL-IO gene therapy Group (IL-1OG) and 
135+20 days in IL-4 and IL-10 combined acne theraov Grow (IL-4&lOGI. The transaene 
and protein expression in IL-4&lOG reached the p&k in pbsioperetive’day (POD)5-8, 
and slowlv reduced thereafter. The reiection score in IL-4&lOG was sionificantlv lower 
(2.2*0.2, bc0.05) than that of CG (3.6iO.2) and IL-1OG (2.7*0.3) in POD<-6, and;.&O.O 
in POD>31. In IL-4&lOG, total graft infiltrating cells was reduced 31% in POD7-10 and 
72% in POD>31, and the percentage of CD3+ T cells was significantly decreased 
(42.7+3.4% in CG, 28.9*5.8% in IL-1OG and 20.9-tO.5% in IL-4&lOG. pcO.01) in POD7- 
10. The percentage of CD4+ T cells was significantly (pqO.01) reduced from 28.9*3.3% 
in CG to 20.9*7.2% in IL-1OG and 13.8+0.3% in IL-4BlOG in POD7-10. The reduction of 
CD&I+ T cells was even more remarkable (19.6+3.4% in CG, 14.1*3.0% in IL-IOG, 
7&0.3% in IL-4&lOG in POD7-10, pcO.01). IL-4 and IL-IO expression was correlated 
with the reduction of the graft infiltrating CD3+ T cells and CD4+/CDB+ ratio (p<O.O5), 
and inversely correlated with the rejection score (p<O.Ol). In IL-4&lOG and IL-lOG, the 
cytotoxic activity of infiltrating T cells III the allografl was greatly reduced (78+8%, and 
69+7%, respectively). 
Conclusion: The liposome-medrated ex viva intracoronary IL-4 and IL-10 combined gene 
